| Preview | Issue Date | Title / Name | Author(s) |
| Sep-2021 | Assessing ISUP prostate cancer grade groups in patients treated with definitive dose escalated external beam radiation | Toby, J.; Eade, T.; Hruby, G.; Kneebone, A.; Aherne, N.; Brown, C.; Guo, L.; Hoffmann, M.; Shaekspeare, T. P.; Aherne, Noel; Hoffmann, Matthew; Shakespeare, Thomas P. | |
| 2020 | Bone health assessment by dual X-ray absorptiometry (DXA) scan in men commencing adjuvant androgen deprivation therapy (ADT) for prostate cancer. | Pan, B.; Aherne, N.; Shakespeare, T.; Grossmann, M.; Wong, P.; Pan, Belinda; Aherne, Noel; Shakespeare, Thomas P. | |
| Jan-2017 | Hippocampal avoidance prophylactic cranial irradiation in small cell lung carcinoma | Aherne, N.; Tune, D.; Ross, A.; Dwyer, P.; Last, A.; Aherne, Noel; Tune, Deanna; Ross, A.; Last, Andrew | |
| Jan-2014 | Improved outcomes with intensity modulated radiation therapy combined with temozolomide for newly diagnosed glioblastoma multiforme | Aherne, N.; Benjamin, L. C.; Horsely, P. J.; Silva, T.; Wilcox, S.; Amalaseelan, J.; Dwyer, P.; Tahir, A. M. R.; Hill, J.; Last, A.; Hansen, C.; McLachlan, C. S.; Lee, Y. L.; McKay, M. J.; Shakespeare, T. P.; Aherne, Noel; Benjamin, Linus C.; Horsley, Patrick J.; Wilcox, Shea; Tahir, Abdul M. R.; Hill, Jacques; Hansen, Carmen; Shakespeare, Thomas P. | |
| Mar-2019 | An investigation of the incidence and severity of patient related side effects following radiation therapy treatment of the head and neck | Winkley, L.; Surjan, Y.; Aherne, N.; Warren-Forward, H.; Aherne, Noel | |
| Oct-2016 | Long-Term Decision Regret After Postprostatectomy Image Guided Intensity Modulated Radiation Therapy | Shakespeare, T. P.; Chin, S.; Hoffman, M.; Aherne, N.; Shakespeare, Thomas P.; Hoffman, Matthew; Aherne, Noel | |
| Dec-2019 | PSMA-PET guided dose-escalated volumetric arc therapy (VMAT) for newly diagnosed lymph node positive prostate cancer: Efficacy and toxicity outcomes at two years | Shakespeare, T. P.; Eggert, E.; Wood, M.; Westhuyzen, J.; Turnbull, K.; Rutherford, N.; Aherne, N.; Shakespeare, Thomas P.; Eggert, Elizabeth; Wood, Maree; Westhuyzen, Justin; Turnbull, Kristy; Aherne, Noel | |
| Jun-2023 | PSMA-PET-guided dose-escalated volumetric arc therapy for newly diagnosed lymph node-positive prostate cancer: 5 Year outcomes following the FROGG and EviQ node-positive guidelines | Yap, S. Z. L; Armstrong, S.; Aherne, N.; Shakespeare, T. P.; Yap, Shaun Z.; Aherne, Noel; Shakespeare, Thomas P. | |
| Dec-2023 | SABR for Early Non-Small Cell Lung Cancer: Changes in Pulmonary Function, Dyspnea, and Quality of Life | Ahn, J.; Yeghiaian-Alvandi, R.; Hegi-Johnson, F.; Browne, L. H.; Graham, P. H.; Chin, Y.; Gee, H.; Vinad, S.; Ludbrook, J.; Last, A; Dwyer, P.; Ong, A.; Aherne, N.; Azzi, M.; Hau, E.; Last, Andrew; Aherne, Noel | |
| Oct-2019 | Validation of the prognostic ability of the five-tiered ISUP grade groups for prostate cancer treated with definitive dose-escalated external beam radiation treatment in a contemporary Australian population | Toby, J.; Shakespeare, T. P.; Aherne, N.; Brown, C.; Guo, L.; Hoffman, M.; Hruby, G.; Kneebone, A.; Eade, T.; Shakespeare, Thomas P.; Aherne, Noel; Hoffmann, Matthew | |
